http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109662968-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bf1199c0bce1e588e0be573c5c8fe51 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569 |
| filingDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9880c12e78c223377f6f830335ffea77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98a65714ab244d2e4deeae6ea3fbf7ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0820904a6ba37fe810ce6015b2bb7499 |
| publicationDate | 2019-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109662968-A |
| titleOfInvention | Whitening preparation containing A-anocarb-5α androstane compound and its application |
| abstract | The invention provides a whitening preparation containing A-decarb-5α androstane compound and its application. Specifically, the present invention provides the use of an A-decarb-5α androstane compound for preparing a preparation or composition, the preparation or composition (a) for increasing the number of leukocytes; or (b) For the prevention or treatment of leukopenia. The A-decarb-5α androstane compound can obviously relieve and improve the reduction of leukocyte count caused by anti-tumor drugs (such as cyclophosphamide and other chemotherapy drugs) or radiotherapy, and has obvious curative effect, small side effects and convenient use. In addition, administration of the A-decarb-5α androstane compound prior to chemotherapy or radiotherapy prevented the decline in white blood cell counts without significant reductions over an extended period of time. |
| priorityDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 183.